SETONDA is a dynamically developing pharmaceutical company established in November 2012 within the GMG Group to research, develop and produce high quality innovative pharmaceutical products  with patient focus to reach end users and health care providers all over Europe.

SETONDA specializes in the research, development, production processes and market access of modern, innovative products and value-added generics based on organic, synthetic and herbal compounds.

GMG Group aims to further specialize in intra-group product  research and development processes, by consolidating all R&D activities in Spain under SETONDA

SETONDA has also established strategic collaborations and cooperation with many international pharmaceutical companies at all pre-production stages such as product development, clinical and preclinical studies, laboratory testing, and preparation processes for GMP audit inspections by EU health authorities

Develop new innovative technologies in order to improve production capabilities and qualities

Preclinical and clinical studies of products developed by the company in compliance with the evidence-based clinical standards;

Production of active components and finished goods with proven effectiveness and safety in compliance with the European quality standards (EU Good Manufacturing Practices);

Organization of registration, promotion and advertisement of innovative products developed by the company in strict coordination with the local legal requirements and ethical business practices;

Full compliance  with the European quality standards (EU Good Distribution Practices) in distribution and logistics operations.

To actively support educational programs in full cooperation with scientific institutions in order to introduce innovative treatment methods and to increase the efficiency and safety of treatment.

Increase diseases awareness among the community in order to improve their quality of life and reach alternative therapies.